Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\class-wp-theme.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\class-wp-theme.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-taxonomies-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-taxonomies-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-application-passwords-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\rest-api\endpoints\class-wp-rest-application-passwords-controller.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\block-patterns.php on line 1

Notice: Uninitialized string offset: 0 in C:\webapps\propertymentorgroup\wp-includes\block-patterns.php on line 1
Stock Alert: Exelixis (NASDAQ:EXEL), Whiting USA Trust II (NYSE:WHZ), Walgreen Co. (NYSE:WAG), Mercantile Bank Corp. (NASDAQ:MBWM), Avalon Holdings Corp. (NYSEMKT:AWX) - Property Mentor Group

Stock Alert: Exelixis (NASDAQ:EXEL), Whiting USA Trust II (NYSE:WHZ), Walgreen Co. (NYSE:WAG), Mercantile Bank Corp. (NASDAQ:MBWM), Avalon Holdings Corp. (NYSEMKT:AWX)


Exelixis (NASDAQ:EXEL) announced December, 03, that treatment with cabozantinib failed to alleviate bone pain compared to a steroid control in men with advanced, metastatic prostate cancer. A negative outcome from the so-called COMET-2 prostate cancer study of cabozantinib was widely expected given the previously announced failure of the COMET-1 study in September. S Exelixis, Inc. (NASDAQ:EXEL) in last trading activity decreased -2.88% to close at $1.35. Company weekly performance is -10.00% while its quarterly performance stands at -29.32%. Exelixis, Inc. (NASDAQ:EXEL) is -83.95% away from its 52 week high.

Whiting USA Trust II (NYSE:WHZ) was downgraded by investment analysts at Raymond James from a “market perform” rating to an “underperform” rating in a note issued to investors on Monday, TheFlyOnTheWall.com reports. On last trading day Whiting USA Trust II (NYSE:WHZ) advanced 7.02% to close at $6.86. Its volatility for the week is 11.74% while volatility for the month is 6.17%. Whiting USA Trust II (NYSE:WHZ) monthly performance is -39.35%.

Drugstore chain Walgreen Co. (NYSE:WAG) said Wednesday that Greg Wasson, president and chief executive officer of the company, will retire after the close of Walgreens’ merger with Switzerland-based Alliance Boots GmbH. The announcement marks a reversal from Walgreens’ announcement in August that Wasson would be president and CEO of the combined company. Walgreen Co. (NYSE:WAG) in last trading activity moved down -0.64% to close at $68.15. Company weekly performance is 1.14% while its quarterly performance stands at 7.97%. Walgreen Co. (NYSE:WAG) is -9.84% away from its 52 week high.

On Dec 01, Primatics Financial (“Primatics”), was selected by Mercantile Bank Corp. (NASDAQ:MBWM) to implement its EVOLV® software solution to efficiently and cost-effectively manage the loan accounting and credit analysis for Mercantile’s integration with Firstbank Corporation (“Firstbank”) (NASDAQ: FBMI). Mercantile Bank Corp. (NASDAQ:MBWM) has 1.40% insider ownership while its institutional ownership stands at 44.00%. In last trading activity company’s stock closed at $19.57.

On Dec. 2, Ronald E. Klingle, Chairman of the Board of Avalon Holdings Corporation (NYSE:AWX), announced that effective December 1, 2014, Bryan P. Saksa, has been hired as Treasurer and Chief Financial Officer replacing Timothy C. Coxson. On Wednesday shares of Avalon Holdings Corp. (NYSEMKT:AWX) closed at $3.40. Company’s sales growth for last 5 years was 4.00%.


Leave a Reply

Your email address will not be published. Required fields are marked *